Experimental Study on Protective Role of NSAID on Articular Cartilage Destruction in Septic Arthritis

Document Type : RESEARCH PAPER


1 Bone and Joint research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2 Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran


Background: Surgical drainage and antibiotic therapy are the cornerstones of treatment protocols in septic arthritis; however, in some circumstances, the diagnosis and initiation of treatment may be retarded by slow disease progression or the time when the patient’s condition precludes early surgery. Therefore, it is beneficial to find ways to reduce the amount of articular injury. This study aimed to evaluate the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the prevention of articular cartilage damage in an animal model of staphylococcal septic arthritis.
Methods: Knee joints of 40 rabbits were infected by the intra-articular injection of 105 colony-forming units of Staphylococcus aureus. Subsequently, they were categorized into four groups. The first (i.e., control group) and second groups were treated with a placebo and intramuscular injection of Ceftriaxone, respectively. Moreover, the third and fourth groups were treated with Naproxen alone and a combination of Ceftriaxone and Naproxen, respectively. All medications were started 24 h after the inoculation of microorganisms into the knee joint and continued for 3 days. Following that, the cartilage was evaluated using the International Cartilage Repair Society (ICRS) Visual Histological Assessment Scale.
Results: The group treated with the combination of Ceftriaxone and Naproxen obtained better results in terms of cell viability in tibial side cartilage and surface in both tibial and femoral cartilages (p <0.0125), compared to the group treated with antibiotics alone.
Conclusion: According to the results, in case of septic arthritis, the early administration of NSAID in conjunction with an appropriate systemic antibiotic may decrease further articular cartilage damage that is evoked by an infection.
Level of evidence: III


Main Subjects

1. Shirtliff ME, Mader JT. Acute septic arthritis. Clin
Microbiol Rev. 2002; 15(4):527-44.
2. Stricker SJ, Lozman PR, Makowski AL, Gunja-Smith
Z. Chondroprotective effect of betamethasone in
lapine pyogenic arthritis. J Pediatr Orthop. 1996;
3. Sophia Fox AJ, Bedi A, Rodeo SA. The basic science
of articular cartilage: structure, composition, and
function. Sports Health. 2009; 1(6):461-8.
4. Kumar V. Robbbins and Cotran pathologic basis of
disease. 8th ed. Philadelphia: Saunders Elsevier;
2010. P. 1235.
5. Smith RL, Kajiyama G, Schurman DJ. Staphylococcal
septic arthritis: antibiotic and nonsteroidal antiinflammatory
drug treatment in a rabbit model. J
Orthop Res. 1997; 15(6):919-26.
6. Vignon E, Mathieu P, Louisot P, Richard M. In vitro 
effect of nonsteroidal antiinflammatory drugs on
proteoglycanase and collagenase activity in human
osteoarthritic cartilage. Arthritis Rheum. 1991;
7. Daum RS, Davis WH, Farris KB, Campeau RJ, Mulvihill
DM, Shane SM. A model of Staphylococcus aureus
bacteremia, septic arthritis, and osteomyelitis in
chickens. J Orthop Res. 1990; 8(6):804-13.
8. Hoemann C, Kandel R, Roberts S, Saris DB, Creemers
L, Mainil-Varlet P, et al. International Cartilage
Repair Society (ICRS) recommended guidelines for
histological endpoints for cartilage repair studies
in animal models and clinical trials. Cartilage. 2011;
9. Mann HB, Whitney DR. On a test of whether one of
two random variables is stochastically larger than
the other. Ann Math Statist. 1947; 18(1):50-60.
Volume 8, Issue 1
January 2020
Pages 89-93
  • Receive Date: 31 January 2019
  • Revise Date: 31 May 2019
  • Accept Date: 28 September 2019
  • First Publish Date: 01 January 2020